Skip to 0 minutes and 7 secondsIn this fourth and last week of this course, we present a third development of nanotechnology and health care-- the detection of so-called hypermethylated DNA in urine. This substance is a biomarker for bladder cancer. Here, lab on a chip technology is combined with a nanosensor to measure the extremely low concentrations of this hypermethylated DNA in urine. The main lecturer of this week is Professor Loes Segerink. She is the principal investigator and driver of the research program that aims at the realization of a sensor to detect bladder cancer.
Welcome to week 4
Welcome to the fourth and final week of this course. Martin Bennink introduces the detection of cancer in urine, using lab-on-a-chip technology.
Our main lecturer this week is Dr. Loes Segerink, from the BIOS Lab-on-a-chip group, with special focus on Biomedical Microdevices. Her research is part of both the MIRA and MESA+ Institutes. For this research she collaborates with researchers and clinicians of the VU Medical Center in Amsterdam.
© University of Twente